| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 11 | -291,221 | 100% | $39.45 | -$11,489,004 |
| Net | -11 | -291,221 | -100% | -$11,489,004 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marc Stapley | Chief Executive Officer, Director | $15,674,903 | -$2,231,803 | -12% | 06 Mar 2026 |
| Rebecca Chambers | Chief Financial Officer | $6,293,415 | -$1,571,824 | -20% | 06 Mar 2026 |
| Annie McGuire | SVP, General Counsel | $5,365,372 | -$1,178,356 | -18% | 06 Mar 2026 |
| Phillip G. Febbo | Chief Scientific & Med Officer | $5,351,951 | -$786,138 | -13% | 06 Mar 2026 |
| John Leite | Chief Commercial Officer-CLIA | $5,240,817 | -$551,475 | -9.5% | 06 Mar 2026 |
| Tina S. Nova | President, CLIA U.S. | $4,779,054 | 03 Mar 2022 | ||
| Bonnie H. Anderson | Director | $4,675,738 | 02 Jun 2023 | ||
| Robert S. Epstein | Director | $2,190,405 | -$753,204 | -26% | 01 Oct 2025 |
| Giulia C. Kennedy | Chief Scientific & Med Officer | $1,750,844 | 06 Dec 2022 | ||
| Jonathan Wygant | VP, Chief Accounting Officer | $1,583,829 | -$449,907 | -22% | 06 Mar 2026 |
| Evan/ Fa Jones | Director | $1,475,419 | -$2,001,863 | -58% | 25 Nov 2025 |
| Eliav Barr | Director | $1,474,755 | 18 Jun 2025 | ||
| John L. Bishop | Director | $1,277,388 | 17 Jul 2023 | ||
| Jens Holstein | Director | $1,175,255 | -$423,563 | -26% | 20 Nov 2025 |
| Muna Bhanji | Director | $1,132,521 | -$122,367 | -9.8% | 18 Jun 2025 |
| Thomas F. Miller | Director | $744,104 | 18 Jun 2025 | ||
| David Brent Shafer | Director | $744,104 | 18 Jun 2025 | ||
| Karin Eastham | Director | $631,478 | -$1,418,502 | -69% | 05 Dec 2025 |
| Beverly Jane Alley | VP, Corporate Controller | $345,020 | 17 May 2021 | ||
| Kevin K. Gordon | Director | $231,429 | 08 Jun 2022 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jonathan Wygant | VCYT | Common Stock | Award | 30.2% | 10,525 | 45,434 | 06 Mar 2026 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Award | 62.5% | 59,206 | 153,912 | 06 Mar 2026 | Direct | ||
| Phillip G. Febbo | VCYT | Common Stock | Award | 30.8% | 36,181 | 153,527 | 06 Mar 2026 | Direct | ||
| John Leite | VCYT | Common Stock | Award | 39.8% | 42,759 | 150,339 | 06 Mar 2026 | Direct | ||
| Marc Stapley | VCYT | Common Stock | Award | 25.8% | 92,099 | 449,653 | 06 Mar 2026 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Award | 37.6% | 49,338 | 180,534 | 06 Mar 2026 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Sale | -12.3% | $662,869 | $36.14 | -18,341 | 131,196 | 04 Mar 2026 | Direct |
| Marc Stapley | VCYT | Common Stock | Sale | -11.3% | $1,637,594 | $35.97 | -45,523 | 357,554 | 04 Mar 2026 | Direct |
| John Leite | VCYT | Common Stock | Sale | -4.66% | $185,083 | $35.19 | -5,260 | 107,580 | 04 Mar 2026 | Direct |
| Annie McGuire | VCYT | Common Stock | Sale | -6.57% | $236,725 | $35.55 | -6,658 | 94,706 | 04 Mar 2026 | Direct |
| Annie McGuire | VCYT | Common Stock | Tax liability | -6.38% | -6,902 | 101,364 | 02 Mar 2026 | Direct | ||
| Jonathan Wygant | VCYT | Common Stock | Tax liability | -7.93% | -3,006 | 34,909 | 02 Mar 2026 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Tax liability | -4.61% | -7,234 | 149,537 | 02 Mar 2026 | Direct | ||
| John Leite | VCYT | Common Stock | Tax liability | -6.25% | -7,517 | 112,840 | 02 Mar 2026 | Direct | ||
| Phillip G. Febbo | VCYT | Common Stock | Sale | -10.3% | $485,429 | $36.16 | -13,425 | 117,346 | 02 Mar 2026 | Direct |
| Phillip G. Febbo | VCYT | Common Stock | Tax liability | -4.41% | -6,035 | 130,771 | 02 Mar 2026 | Direct | ||
| Marc Stapley | VCYT | Common Stock | Tax liability | -4.6% | -19,455 | 403,077 | 02 Mar 2026 | Direct | ||
| John Leite | VCYT | Common Stock | Tax liability | -6.89% | -8,905 | 120,357 | 26 Feb 2026 | Direct | ||
| John Leite | VCYT | Common Stock | Award | 57.4% | 47,149 | 129,262 | 26 Feb 2026 | Direct | ||
| Marc Stapley | VCYT | Common Stock | Tax liability | -7.82% | -35,841 | 422,532 | 26 Feb 2026 | Direct | ||
| Marc Stapley | VCYT | Common Stock | Award | 43.6% | 139,074 | 458,373 | 26 Feb 2026 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Tax liability | -7.14% | -12,049 | 156,771 | 26 Feb 2026 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Award | 54.2% | 59,324 | 168,820 | 26 Feb 2026 | Direct | ||
| Phillip G. Febbo | VCYT | Common Stock | Tax liability | -15.2% | -24,486 | 136,806 | 26 Feb 2026 | Direct | ||
| Phillip G. Febbo | VCYT | Common Stock | Award | 80.2% | 71,806 | 161,292 | 26 Feb 2026 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Tax liability | -9.12% | -10,867 | 108,266 | 26 Feb 2026 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Award | 74.8% | 50,999 | 119,133 | 26 Feb 2026 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Sale | -13.7% | $463,204 | $43.13 | -10,739 | 67,760 | 16 Dec 2025 | Direct |
| Karin Eastham | VCYT | Common Stock | Sale | -59.6% | $908,923 | $45.45 | -20,000 | 13,554 | 05 Dec 2025 | Direct |
| Karin Eastham | VCYT | Common Stock | Options Exercise | 147.6% | 20,000 | 33,554 | 05 Dec 2025 | Direct | ||
| Karin Eastham | VCYT | Stock Option (right to buy) | Options Exercise | -100% | -20,000 | 0 | 05 Dec 2025 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Sale | -1.78% | $67,261 | $47.30 | -1,422 | 78,499 | 04 Dec 2025 | Direct |
| Rebecca Chambers | VCYT | Common Stock | Sale | -10.8% | $621,955 | $46.84 | -13,278 | 109,496 | 04 Dec 2025 | Direct |
| Marc Stapley | VCYT | Common Stock | Sale | -2.35% | $361,076 | $47.09 | -7,668 | 318,603 | 04 Dec 2025 | Direct |
| John Leite | VCYT | Common Stock | Sale | -1.53% | $60,718 | $47.51 | -1,278 | 82,113 | 04 Dec 2025 | Direct |
| Phillip G. Febbo | VCYT | Common Stock | Tax liability | -3.2% | -2,955 | 89,486 | 02 Dec 2025 | Direct | ||
| Annie McGuire | VCYT | Common Stock | Tax liability | -3.68% | -3,052 | 79,921 | 02 Dec 2025 | Direct | ||
| Rebecca Chambers | VCYT | Common Stock | Tax liability | -2.68% | -3,384 | 122,774 | 02 Dec 2025 | Direct | ||
| Marc Stapley | VCYT | Common Stock | Tax liability | -2.37% | -7,914 | 326,271 | 02 Dec 2025 | Direct | ||
| John Leite | VCYT | Common Stock | Tax liability | -3.36% | -2,900 | 83,391 | 02 Dec 2025 | Direct | ||
| Jonathan Wygant | VCYT | Common Stock | Tax liability | -3.42% | -1,325 | 37,420 | 02 Dec 2025 | Direct | ||
| John Leite | VCYT | Common Stock | Sale | -3.15% | $140,400 | $50.00 | -2,808 | 86,291 | 25 Nov 2025 | Direct |
| Evan/ Fa Jones | VCYT | Common Stock | Sale | -3.63% | $55,576 | $50.25 | -1,106 | 29,362 | 25 Nov 2025 | Direct |
| Jens Holstein | VCYT | Common Stock | Sale | -26.9% | $423,563 | $42.36 | -10,000 | 27,199 | 20 Nov 2025 | Direct |
| Jonathan Wygant | VCYT | Common Stock | Sale | -11.6% | $215,978 | $42.33 | -5,102 | 38,745 | 10 Nov 2025 | Direct |
| Jonathan Wygant | VCYT | Common Stock | Sale | -11.7% | $233,929 | $40.21 | -5,818 | 43,847 | 07 Nov 2025 | Direct |
| Annie McGuire | VCYT | Common Stock | Sale | -7.23% | $258,640 | $40.00 | -6,466 | 82,973 | 05 Nov 2025 | Direct |
| Rebecca Chambers | VCYT | Common Stock | Sale | -5.26% | $287,000 | $41.00 | -7,000 | 126,158 | 05 Nov 2025 | Direct |
| Karin Eastham | VCYT | Common Stock | Sale | -41.6% | $387,191 | $40.02 | -9,674 | 13,554 | 05 Nov 2025 | Direct |
| Evan/ Fa Jones | VCYT | Common Stock | Sale | -58.6% | $1,946,288 | $45.06 | -43,196 | 30,468 | 05 Nov 2025 | Direct |